Oral Vinorelbine as Induction Chemotherapy Followed Concomitant Chemoradiotherapy

NCT01839032 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Vinorelbine cisplatin radiotherapy

Sponsor

Pierre Fabre Medicament